Michelle Galloway’s Post

In an article spotlighting Cooley LLP's 2023 Life Sciences Group of the Year recognition, Law360 spoke with partners Marc Recht and Chad Shear, as they discussed how the firm's longstanding biotech industry leadership, collaborative workplace culture and breadth of practice play key roles in Cooley's accomplishments across the life sciences ecosystem. Subscribers can read more with the link below. #TeamCooley

In an article spotlighting Cooley LLP's 2023 Life Sciences Group of the Year recognition, Law360 spoke with partners Marc Recht and Chad Shear, as they discussed how the firm's longstanding biotech industry leadership, collaborative workplace culture and breadth of practice play key roles in Cooley's accomplishments across the life sciences ecosystem. Subscribers can read more with the link below. #TeamCooley

In an article spotlighting Cooley LLP's 2023 Life Sciences Group of the Year recognition, Law360 spoke with partners Marc Recht and Chad Shear, as they discussed how the firm's longstanding biotech industry leadership, collaborative workplace culture and breadth of practice play key roles in Cooley's accomplishments across the life sciences ecosystem. Subscribers can read more with the link below. #TeamCooley

In an article spotlighting Cooley LLP's 2023 Life Sciences Group of the Year recognition, Law360 spoke with partners Marc Recht and Chad Shear, as they discussed how the firm's longstanding biotech industry leadership, collaborative workplace culture and breadth of practice play key roles in Cooley's accomplishments across the life sciences ecosystem. Subscribers can read more with the link below. #TeamCooley

A great pairing if you ask me! Two of Cooley's most prolific attorneys talk to Law360 about the #Cooley difference. Since facilitating the first biotech IPO in history, our attorneys have remained at the forefront of the innovation ecosystem, expertly guiding clients from R&D to Commercialization and beyond, and everything in between. Check it out... cc: Marc Recht & Chad Shear

In an article spotlighting Cooley’s 2023 Life Sciences Group of the Year recognition, Law360 spoke with partners Marc Recht and Chad Shear, as they discussed how the firm's longstanding biotech industry leadership, collaborative workplace culture and breadth of practice play key roles in Cooley's accomplishments across the life sciences ecosystem. Subscribers can read more with the link below. Cooley's global life sciences practice spans corporate, litigation, regulatory and intellectual property capabilities, with almost 280 partners, associates, paralegals and other legal professionals attached to life sciences work of some kind across all 19 offices. Learn more here: https://bit.ly/49Kvv8f #lifesciences #leadership #biotech #TeamCooley

Excited to lead this dinner discussion. If we're all using the same list building DB/Tech, no advantage. Of recent, there has been a wave of startups that aggregate traditional and disparate private company data sources. Over dinner, we'll discuss how we use tech now, and how some of these new tools (Yes, some with AI!) might create an advantage. Dinner attendees encouraged to share their best practices (even if they're analog). https://lnkd.in/ebf-YCwC #dealsourcing #acgnewjersey #CDForumDinner

Learn more about Flagship’s recently announced Chief Business Development Officer Amanda Kay, Ph.D. in this Three Questions video, including what drew her to Flagship, what she’s learned from her career advancing corporate strategy in biotech and pharma, and what she likes to do for fun outside of the office. ⬇

An interesting forthcoming session for any Biotechs in my network who are considering CRO selection for an upcoming clinical trial. Kieran Canisius has a wealth of knowledge on this topic - this webinar is a must! #BiotechExcellence #CROSelection #BiotechWebinar

Experiencing slow enrollment in your study? Considering a hybrid approach? Beware of common misconceptions about the design and execution of DCTs and engage with experts with real-world experience. At UBC, we understand the importance of debunking DCT mythologies and authentically address key considerations necessary to execute a successful hybrid study design strategy. Learn how UBC can help https://hubs.li/Q02KtXtF0 #PatientsFirst #DCT #Pharma #RWE